Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
about
Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistanceAbsence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected miceNew strategies against drug resistance to herpes simplex virusCRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic VirusesHeterogeneity and evolution of thymidine kinase and DNA polymerase mutants of herpes simplex virus type 1: implications for antiviral therapy.Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and managementGenotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapyRecurrent antiviral-resistant genital herpes in an immunocompetent patient.Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency.Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.The antiviral effect of jiadifenoic acids C against coxsackievirus B3.Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective.A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1Famciclovir: a focus on efficacy and safety.Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2.Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis.Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudinAdenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system.Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir.Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient.Single-day famciclovir for the treatment of genital herpes: follow-up results of time to next recurrence and assessment of antiviral resistance.Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient.Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies.
P2860
Q24634966-4F257F32-E6C7-40A5-A65C-90489518A6ADQ24797196-9AD6E1CD-FC56-4174-B2F5-92203719CFC5Q26749548-1F1D6B01-B746-4063-B400-34241590ED8FQ26766798-F476A6FA-2DA8-459E-A605-595DC6CF68C8Q34035099-FFBC050A-ED14-4CEE-9BBF-32B067DE31D9Q34113580-399052A0-9BB5-43F3-8113-B3825CEF0643Q34149904-5D5EC9B0-2349-443F-AF08-BF5F6B3FE976Q34290117-125024FB-960C-41D1-ADAB-36BCE9545491Q34579981-301CC701-1EC7-4558-B127-3B7379462E1CQ34698957-D0399381-E50C-42A6-8E14-B21413CA1D3EQ34861045-76F58870-CADF-434D-ACFC-85A6389F4F50Q34938781-A163C9F3-1336-43B4-9283-9134BF326708Q35826062-3FB7E44F-2CEC-4E3A-AC79-B2B4ED76485EQ36237575-5A994848-459A-4832-BC8F-2311A2835086Q36632255-6D722245-895F-41A7-B530-3681B920C6E5Q37059841-2CE97AA1-13F9-4E2D-B1D7-A76E0EB085A2Q37739461-315E4B50-35F7-4363-87E9-40AE5F08A312Q38598512-B4DACA39-4D5C-4501-92B4-185560C6A732Q39652814-A12E022B-612C-4DB3-AA77-ACF87789D751Q41891671-52DB2F29-525A-4322-9A5F-331425645A9AQ42806164-17ADC009-7FF2-42C9-85D7-01D847FE53C0Q43801613-4AB5B145-0728-43FC-BBF1-5C764463D7D1Q44235197-EAC73A22-F5ED-46AC-8894-1CD036BFD9E6Q45206133-32D67074-C2EA-473C-94BF-F9DC574146DEQ45404650-3AE0CC5B-94A9-4DDE-8407-1FF664F80700Q47108365-44CCB183-9C1F-4B4A-872B-F14AE747AE4F
P2860
Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Characterization of herpes sim ...... e to penciclovir or acyclovir.
@en
Characterization of herpes sim ...... e to penciclovir or acyclovir.
@nl
type
label
Characterization of herpes sim ...... e to penciclovir or acyclovir.
@en
Characterization of herpes sim ...... e to penciclovir or acyclovir.
@nl
prefLabel
Characterization of herpes sim ...... e to penciclovir or acyclovir.
@en
Characterization of herpes sim ...... e to penciclovir or acyclovir.
@nl
P2093
P2860
P1433
P1476
Characterization of herpes sim ...... e to penciclovir or acyclovir.
@en
P2093
J O'Leary Bartus
M M Van Horn
R J Wittrock
R T Sarisky
S Van Horn
P2860
P304
P356
10.1128/JVI.75.4.1761-1769.2001
P407
P577
2001-02-01T00:00:00Z